467 related articles for article (PubMed ID: 8084301)
21. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1.
Gutierrez LS; Schulman A; Brito-Robinson T; Noria F; Ploplis VA; Castellino FJ
Cancer Res; 2000 Oct; 60(20):5839-47. PubMed ID: 11059781
[TBL] [Abstract][Full Text] [Related]
22. [Effect of 17 beta-estradiol on activity and gene expression of fibrinolytic factor in human umbilical vein endothelial cell].
Zhang Y; Zhu G; Duan Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Oct; 21(5):326-30. PubMed ID: 12567428
[TBL] [Abstract][Full Text] [Related]
23. Dexamethasone increased plasminogen activator inhibitor-1 expression on human umbilical vein endothelial cells: an additive effect to tumor necrosis factor-alpha.
Yamamoto Y; Ishizu A; Ikeda H; Otsuka N; Yoshiki T
Pathobiology; 2004; 71(6):295-301. PubMed ID: 15627839
[TBL] [Abstract][Full Text] [Related]
24. Plasminogen activator inhibitor type-1 mutants regulate angiogenesis of human umbilical and lung vascular endothelial cells.
Chorostowska-Wynimko J; Swiercz R; Skrzypczak-Jankun E; Selman SH; Jankun J
Oncol Rep; 2004 Dec; 12(6):1155-62. PubMed ID: 15547731
[TBL] [Abstract][Full Text] [Related]
25. Deacylated lipopolysaccharide inhibits plasminogen activator inhibitor-1, prostacyclin, and prostaglandin E2 induction by lipopolysaccharide but not by tumor necrosis factor-alpha.
Riedo FX; Munford RS; Campbell WB; Reisch JS; Chien KR; Gerard RD
J Immunol; 1990 May; 144(9):3506-12. PubMed ID: 2109778
[TBL] [Abstract][Full Text] [Related]
26. Herpes simplex virus decreases endothelial cell plasminogen activator inhibitor.
Bok RA; Jacob HS; Balla J; Juckett M; Stella T; Shatos MA; Vercellotti GM
Thromb Haemost; 1993 Mar; 69(3):253-8. PubMed ID: 7682340
[TBL] [Abstract][Full Text] [Related]
27. [Testosterone's effect on tPA and PAI-1 mRNA levels of HUVEC].
Jin H; Li YG; Wang DM; Tan XR
Zhonghua Nan Ke Xue; 2005 Aug; 11(8):584-6. PubMed ID: 16138576
[TBL] [Abstract][Full Text] [Related]
28. Astrocyte regulation of human brain capillary endothelial fibrinolysis.
Kim JA; Tran ND; Wang SJ; Fisher MJ
Thromb Res; 2003; 112(3):159-65. PubMed ID: 14967413
[TBL] [Abstract][Full Text] [Related]
29. VEGF increases the fibrinolytic activity of endothelial cells within fibrin matrices: involvement of VEGFR-2, tissue type plasminogen activator and matrix metalloproteinases.
Ratel D; Mihoubi S; Beaulieu E; Durocher Y; Rivard GE; Gingras D; Béliveau R
Thromb Res; 2007; 121(2):203-12. PubMed ID: 17512973
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of endothelial cell expression of plasminogen activator inhibitor type-1 by gemfibrozil.
Fujii S; Sawa H; Sobel BE
Thromb Haemost; 1993 Oct; 70(4):642-7. PubMed ID: 7509512
[TBL] [Abstract][Full Text] [Related]
31. [Effect of AP-1 on expression of plasminogen activator inhibitor-1 in human vascular endothelial cells].
Li XD; Zu SY; Wang W; Zhu GJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):307-11. PubMed ID: 12905745
[TBL] [Abstract][Full Text] [Related]
32. Enhanced tissue factor activity and plasminogen activator inhibitor-1 antigen in human umbilical vein endothelial cells incubated with lipoproteins.
Kaneko T; Wada H; Wakita Y; Minamikawa K; Nakase T; Mori Y; Deguchi K; Shirakawa S
Blood Coagul Fibrinolysis; 1994 Jun; 5(3):385-92. PubMed ID: 8075310
[TBL] [Abstract][Full Text] [Related]
33. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
[TBL] [Abstract][Full Text] [Related]
34. Glucagon-like peptide-1 attenuates tumour necrosis factor-alpha-mediated induction of plasminogen [corrected] activator inhibitor-1 expression.
Liu H; Hu Y; Simpson RW; Dear AE
J Endocrinol; 2008 Jan; 196(1):57-65. PubMed ID: 18180317
[TBL] [Abstract][Full Text] [Related]
35. Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro.
Kaye SA; Louise CB; Boyd B; Lingwood CA; Obrig TG
Infect Immun; 1993 Sep; 61(9):3886-91. PubMed ID: 8359910
[TBL] [Abstract][Full Text] [Related]
36. Indispensable role of tissue-type plasminogen activator in growth factor-dependent tube formation of human microvascular endothelial cells in vitro.
Sato Y; Okamura K; Morimoto A; Hamanaka R; Hamaguchi K; Shimada T; Ono M; Kohno K; Sakata T; Kuwano M
Exp Cell Res; 1993 Feb; 204(2):223-9. PubMed ID: 7679996
[TBL] [Abstract][Full Text] [Related]
37. Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro.
Louise CB; Obrig TG
Infect Immun; 1992 Apr; 60(4):1536-43. PubMed ID: 1548077
[TBL] [Abstract][Full Text] [Related]
38. Sensitization of human umbilical vein endothelial cells to Shiga toxin: involvement of protein kinase C and NF-kappaB.
Louise CB; Tran MC; Obrig TG
Infect Immun; 1997 Aug; 65(8):3337-44. PubMed ID: 9234795
[TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome.
van de Kar NC; Monnens LA; Karmali MA; van Hinsbergh VW
Blood; 1992 Dec; 80(11):2755-64. PubMed ID: 1333300
[TBL] [Abstract][Full Text] [Related]
40. Senescence-dependent regulation of type 1 plasminogen activator inhibitor in human vascular endothelial cells.
Comi P; Chiaramonte R; Maier JA
Exp Cell Res; 1995 Jul; 219(1):304-8. PubMed ID: 7628547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
